CECentral - Pediatrics ActivitiesLive and Online CME/CE/CEUs for Healthcare Professionals seeking certified professional development.https://www.cecentral.com/rss2024-03-28T21:47:39+00:00℗ & ©The University of KentuckyFeedCreator 1.8 (info@mypapit.net)Compassionate Care: Considerations When Working with Families Impacted by Substance Use Disorder2024-03-29T01:47:39+00:002024-03-29T01:47:39+00:00https://www.cecentral.com/activity/25356info@cecentral.comStigma and discrimination remain large barriers to care access and care quality for pregnant and parenting people with substance use disorder.Stigma and discrimination remain large barriers to care access and care quality for pregnant and parenting people with substance use disorder.Neonatal Opioid Withdrawal Syndrome and Health Equity2024-03-29T01:47:39+00:002024-03-29T01:47:39+00:00https://www.cecentral.com/activity/25355info@cecentral.comOpioid use disorder among pregnant and postpartum women and infants is a complex public health challenge. This presentation shares current initiatives and best practices for preventing misuse and improving care.Opioid use disorder among pregnant and postpartum women and infants is a complex public health challenge. This presentation shares current initiatives and best practices for preventing misuse and improving care.Cultivating Joy and Recovery: Caring for Pregnant and Parenting Patients with Opioid and Other Use Disorders (OUD) 2024-03-29T01:47:39+00:002024-03-29T01:47:39+00:00https://www.cecentral.com/activity/25354info@cecentral.comPregnancy in teens and women age 35 or older increases the risk for preeclampsia and gestational high blood pressure. Women with high-risk pregnancies should receive care from a special team of health care providers to ensure the best possible outcomes. Healthcare professionals need to build knowledge and confidence when caring for pregnant and parenting patients with opioid and other use disorders.Pregnancy in teens and women age 35 or older increases the risk for preeclampsia and gestational high blood pressure. Women with high-risk pregnancies should receive care from a special team of health care providers to ensure the best possible outcomes. Healthcare professionals need to build knowledge and confidence when caring for pregnant and parenting patients with opioid and other use disorders.Destigmatizing Pregnant And Parenting Individuals With Substance Use Disorder2024-03-29T01:47:39+00:002024-03-29T01:47:39+00:00https://www.cecentral.com/activity/25347info@cecentral.comStigma and discrimination remain large barriers to care access and care quality for pregnant and parenting people with substance use disorder.Stigma and discrimination remain large barriers to care access and care quality for pregnant and parenting people with substance use disorder.Moral Distress Part 12024-03-29T01:47:39+00:002024-03-29T01:47:39+00:00https://www.cecentral.com/activity/24761info@cecentral.comMoral Distress is an "occupational hazard" for healthcare providers. It describes a situation in which the healthcare provider knows what the ethical/moral course of action is, but is constrained from acting on it. There may be legal, institutional, or social constraints, including patient/surrogate decisions. Moral distress is an integrity-compromising situation, and if unresolved, leads to moral residue, which can cause healthcare providers to have both physical and emotional symptoms. It is a leading cause of retention problems and workplace bullying in certain healthcare professions. This novel educational module and site  will review the definitions, causes, and consequences of moral distress, as well as offer some solutions.Proper definitions of moral distress can improve inter-professional discussions about this phenomenon. Learn "what is moral distress", who is affected, and common situations that create it.This activity has the same content as MORAL DISTRESS PART 1 which expired on June 30, 2017, and June 11, 2023. If you participated and claimed credit for these sessions, you should not claim credit for this module. Moral Distress is an "occupational hazard" for healthcare providers. It describes a situation in which the healthcare provider knows what the ethical/moral course of action is, but is constrained from acting on it. There may be legal, institutional, or social constraints, including patient/surrogate decisions. Moral distress is an integrity-compromising situation, and if unresolved, leads to moral residue, which can cause healthcare providers to have both physical and emotional symptoms. It is a leading cause of retention problems and workplace bullying in certain healthcare professions. This novel educational module and site  will review the definitions, causes, and consequences of moral distress, as well as offer some solutions.Proper definitions of moral distress can improve inter-professional discussions about this phenomenon. Learn "what is moral distress", who is affected, and common situations that create it.This activity has the same content as MORAL DISTRESS PART 1 which expired on June 30, 2017, and June 11, 2023. If you participated and claimed credit for these sessions, you should not claim credit for this module. Tis The Season. . . For Vaccines!: Pediatric Immunizations for the Fall Respiratory Season2024-03-29T01:47:39+00:002024-03-29T01:47:39+00:00https://www.cecentral.com/activity/24753info@cecentral.comThe CDC has newly issued recommendations for the monovalent COVID booster targeting new strains for everyone older than 6 months of age. In addition, there are two new RSV vaccines, one for infants and one for adults. These illnesses account for high levels of hospitalizations while vaccination rates remain low.
The RSV vaccines are new this year and healthcare teams need to gain knowledge of recommendations, effectiveness, and side effects for these new agents. In addition, teams need to be made aware of new recommendations for the new COVID booster.
COVID vaccinations rates remain relatively low in KY (~69% having at least one dose) and there is misinformation around side effects and importance of vaccination with both COVID and RSV vaccines. Healthcare teams need to know how to address misinformation related to fall respiratory virus vaccines.The CDC has newly issued recommendations for the monovalent COVID booster targeting new strains for everyone older than 6 months of age. In addition, there are two new RSV vaccines, one for infants and one for adults. These illnesses account for high levels of hospitalizations while vaccination rates remain low.
The RSV vaccines are new this year and healthcare teams need to gain knowledge of recommendations, effectiveness, and side effects for these new agents. In addition, teams need to be made aware of new recommendations for the new COVID booster.
COVID vaccinations rates remain relatively low in KY (~69% having at least one dose) and there is misinformation around side effects and importance of vaccination with both COVID and RSV vaccines. Healthcare teams need to know how to address misinformation related to fall respiratory virus vaccines.Truth or Consequences – Dispelling Vaccine Myths2024-03-29T01:47:39+00:002024-03-29T01:47:39+00:00https://www.cecentral.com/activity/24752info@cecentral.comThe CDC has newly issued recommendations for the monovalent COVID booster targeting new strains for everyone older than 6 months of age. In addition, there are two new RSV vaccines, one for infants and one for adults. These illnesses account for high levels of hospitalizations while vaccination rates remain low.
The RSV vaccines are new this year and healthcare teams need to gain knowledge of recommendations, effectiveness, and side effects for these new agents. In addition, teams need to be made aware of new recommendations for the new COVID booster.
COVID vaccinations rates remain relatively low in KY (~69% having at least one dose) and there is misinformation around side effects and importance of vaccination with both COVID and RSV vaccines. Healthcare teams need to know how to address misinformation related to fall respiratory virus vaccines.The CDC has newly issued recommendations for the monovalent COVID booster targeting new strains for everyone older than 6 months of age. In addition, there are two new RSV vaccines, one for infants and one for adults. These illnesses account for high levels of hospitalizations while vaccination rates remain low.
The RSV vaccines are new this year and healthcare teams need to gain knowledge of recommendations, effectiveness, and side effects for these new agents. In addition, teams need to be made aware of new recommendations for the new COVID booster.
COVID vaccinations rates remain relatively low in KY (~69% having at least one dose) and there is misinformation around side effects and importance of vaccination with both COVID and RSV vaccines. Healthcare teams need to know how to address misinformation related to fall respiratory virus vaccines.KyPQC: Hot Topics: New AIM Bundle; Postpartum Depression/SUD Screening; Newborn Screening2024-03-29T01:47:39+00:002024-03-29T01:47:39+00:00https://www.cecentral.com/activity/24668info@cecentral.comThis session includes segments with overlapping coverage of screening programs aimed at identifying mental health conditions and substance use disorder in patients presenting to labor and delivery departments and identifying health conditions in newborns.This session includes segments with overlapping coverage of screening programs aimed at identifying mental health conditions and substance use disorder in patients presenting to labor and delivery departments and identifying health conditions in newborns.KyPQC: Preventing Neonatal Abstinence Syndrome2024-03-29T01:47:39+00:002024-03-29T01:47:39+00:00https://www.cecentral.com/activity/24667info@cecentral.comNeonatal Abstinence Syndrome (NAS) describes the constellation of signs and symptoms associated with intrauterine substance exposure. In Kentucky, NAS is a reportable condition that is analyzed and published annually. NAS data is used to dispatch resources and inform policy according to multifaceted prevention and harm reduction strategies.Neonatal Abstinence Syndrome (NAS) describes the constellation of signs and symptoms associated with intrauterine substance exposure. In Kentucky, NAS is a reportable condition that is analyzed and published annually. NAS data is used to dispatch resources and inform policy according to multifaceted prevention and harm reduction strategies.KyPQC: Intimate Partner Violence and Maternal Mortality & Morbidity in Kentucky2024-03-29T01:47:39+00:002024-03-29T01:47:39+00:00https://www.cecentral.com/activity/24666info@cecentral.comThis presentation examines the intricate relationship between substance use disorder, mental health conditions, and intimate partner violence as contributing factors to maternal mortality and injury. Prevention strategies include the expansion of education and preparedness targeting the future health sciences, human services, law, and public health workforce and the formation of a maternal injury surveillance system database.This presentation examines the intricate relationship between substance use disorder, mental health conditions, and intimate partner violence as contributing factors to maternal mortality and injury. Prevention strategies include the expansion of education and preparedness targeting the future health sciences, human services, law, and public health workforce and the formation of a maternal injury surveillance system database.